Clinical Trial Update: Perioperative FLOT vs Adjuvant XELOX for CA Stomach [Phase 3]

View source ↗

Summary

Phase 3 trial updating perioperative FLOT vs adjuvant XELOX for stomach cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Stomach
• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• FLOT
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Cancer of Stomach, Adenocarcinoma | Phase 3 | Status: RECRUITING